Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer (Q37104763)

18 August 2017

1 reference

title

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

Hans Lilja

4

0 references

Andrew Vickers

object named as

Andrew J Vickers

series ordinal

1

0 references

author name string

Caroline Savage

series ordinal

2

1 reference

18 August 2017

M Frank O'Brien

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

8 December 2008

1 reference

Journal of Clinical Oncology

18 August 2017

1 reference

18 August 2017

27

1 reference

18 August 2017

3

1 reference

18 August 2017

398-403

1 reference

Systematic review of statistical methods used in molecular marker studies in cancer

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Predictors of random sextant biopsy outcome in screened men with PSA > 4 ng/mL and a negative sextant biopsy at previous screening. Experience in a population-based screening program in Florence.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Prostate specific antigen density of the transition zone for early detection of prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Assessment of diagnostic tests when disease verification is subject to selection bias

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened P

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645854

The short-term prostate-specific antigen velocity before biopsy can be used to predict prostatic histology

4 December 2018

1 reference

12 December 2020

Role of psa and its indices in determining the need for repeat prostate biopsies

1 reference

12 December 2020

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

1 reference

12 December 2020

Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy

1 reference

12 December 2020

PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence

1 reference

12 December 2020

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

1 reference

12 December 2020

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening

1 reference

12 December 2020

Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer

1 reference

12 December 2020

Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men

1 reference

12 December 2020

Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years

1 reference

12 December 2020

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.18.1685

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19064972

1 reference